Colleyville, TX, United States of America

Patrick John Sadd

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Alcon, Inc.. Active years: 2026.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Patrick John Sadd

Introduction

Patrick John Sadd is an accomplished inventor based in Colleyville, TX (US). He is known for his innovative approach to medical devices, particularly in the field of ophthalmology. His work has significantly impacted surgical procedures, enhancing both efficiency and safety.

Latest Patents

One of Patrick's notable inventions is the illuminating eye depressor. This device is designed to assist during eye surgeries by providing illumination through the sclera. The eye depressor can removably accommodate a light instrument, which helps illuminate the surgical area. This innovation reduces the number of hands required during surgery, making it particularly beneficial in situations where surgical space is limited. Patrick holds 1 patent for this invention.

Career Highlights

Patrick is currently employed at Alcon, Inc., a leading company in eye care products. His role at Alcon allows him to collaborate with other talented professionals in the field. His contributions to the company and the medical community have been invaluable.

Collaborations

Some of Patrick's coworkers include Michael W. Calhoun and Gary Ganiban. Their collective expertise fosters an environment of innovation and excellence in medical device development.

Conclusion

Patrick John Sadd's contributions to the field of ophthalmology through his illuminating eye depressor exemplify the importance of innovation in medical technology. His work continues to influence surgical practices and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…